CHM chimeric therapeutics limited

Ann: Clinical milestones for 2024 & 2023 successes highlighted, page-9

  1. 14,234 Posts.
    lightbulb Created with Sketch. 4253
    I speculate, due to just 1/10 shares on issue compared to IMU and a similar pathway to get the first tech, CHM 1101vs Azer-Cel, approved, that CHM should run higher than IMU. But if the CF33 application data prove what's already been said between the lines then IMU will be shot up sky high. I hold 3 x more CHM than IMU but as outlined above it is hard to tell which one runs first. Best scenario, one runs like crazy, then switching into the other one. Worst case, both go down the drain.

    Should IMU sell one of its assets soon, as the CEO let slip out recently, then CHM should benefit from it too, signalling to the market that Hopper got his Mojo back and his strategies work.

    No definite answer, all pure speculation.

    GLTA
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
-0.001(25.0%)
Mkt cap ! $6.045M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $22.28K 6.311M

Buyers (Bids)

No. Vol. Price($)
78 84735861 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 86304338 23
View Market Depth
Last trade - 14.27pm 25/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.